Heart Rate Characteristics and Clinical Signs in Neonatal Sepsis
Heart Rate Characteristics and Clinical Signs in Neonatal Sepsis
Heart Rate Characteristics and Clinical Signs in Neonatal Sepsis
PEDIATRIC RESEARCH
Copyright 2007 International Pediatric Research Foundation, Inc.
tial false-negative rate, especially when based on small volumes of blood (37). Accordingly, the Centers for Disease
Control recognizes clinical sepsis in infants, which requires
only signs of illness with antibiotic therapy but no positive
blood culture (8). The NICHD Neonatal Research Network
found that both proven sepsis and clinical sepsis were associated with neurodevelopmental impairment in extremely low
birth weight (1000 g, ELBW) infants (9). The common
denominator is the systemic inflammatory response syndrome
(SIRS), the result of the host response to infectious and
noninfectious insults (10). Clearly, new approaches to the
early diagnosis of both proven and clinical neonatal sepsis are
required.
Before physician suspicion of sepsis and SIRS, neonates
have reduced heart rate variability and transient decelerations
similar to the findings in distressed fetuses (11,12). Heart rate
measures optimized to detect these abnormal heart rate characteristics (HRC) (11,1315) were used to develop an HRC
index at one NICU and then validated at another as a predictor
of neonatal infection and death (16 18).
Laboratory tests such as the I:T ratio add predictive information independent of the HRC index (19). Clinicians also
have ready access to many other sources of information about
the status of the infant such as the general appearance, vital
signs, apnea, oxygen requirement, and feeding tolerance. Our
goal in this work was to determine whether the HRC index
added to the clinical information that is already available to
physicians in the diagnosis of late-onset neonatal sepsis.
Accordingly, we developed a clinical illness score that was
specifically relevant to the diagnosis of neonatal sepsis. The
method for development followed that of the Richardson score
(20) for neonatal mortality or prolonged ventilation. Thus
armed, we examined the relationship between HRC and objective measures of clinical illness. The major hypothesis was
that HRC monitoring and clinical signs provide independent
information in the early diagnosis of late-onset clinical and
proven neonatal sepsis.
METHODS
Patient population. We studied all admissions to the University of Virginia NICU from August 2001 to July 2003 who were 7 or more days of age
and had 7 or more days of HRC monitoring. The clinical research protocol
DOI: 10.1203/01.pdr.0000252438.65759.af
222
RESULTS
Clinical and HRC database. Demographics of the patient
population are shown in Table 1. We prospectively recorded
Table 1. Demographics of the study population, and episodes of
acute neonatal illness
Total
1500 g
No. of infants
337
172
Birth weight
1,460 (910, 2, 539) 915 (715, 1, 177)
Gestational age
30 (27, 35)
27 (25, 28)
Male (%)
56
55
Illness events
Positive blood culture (infants)
76 (63)
67 (55)
Negative blood culture (infants)
80 (63)
67 (53)
Results are presented as median (25th, 75th percentiles) or episodes (patients).
223
224
GRIFFIN ET AL.
Figure 1. Graphical representations of the hospital course of three infants. In the upper half of each panel, the bars represent clinical findings listed on the right
axis, and darker shading reflects more severely abnormal findings and higher clinical point scores (light gray 0 points, gray 1 point, black 2 points). In the bottom
half, the noisy line is the HRC index and the dashed lines are the clinical score.
Points
2
2
2
1
1
1
1
1
225
Figure 3. Odds ratios for clinical findings and the HRC index in the
prediction of clinical and proven sepsis in the next 24 h. Horizontal lines are
95% confidence limits. The inset above shows the time window for training
the models the 24 h preceding, but not including, the time of the blood
culture obtained for suspicion of sepsis (BC).
Figure 4. Odds ratios for clinical findings and the HRC index at the time of
diagnosis of clinical and proven sepsis. Horizontal lines are 95% confidence
limits. The inset above shows the time window for training the models the
6 h preceding and 18 h following the time of the blood culture obtained for
suspicion of sepsis (BC).
Figure 6. A risk assessment card for neonatal sepsis based on clinical signs
and HRC monitoring.
226
GRIFFIN ET AL.
clinical score and HRC monitoring. When neither is measured, the fold-increase in risk of illness is 1.0. The clinical
score alone differentiates infants across a spectrum of risk, as
does the HRC index. Knowledge of both allows greater
refinement in the estimation of risk. For example, an infant
with a clinical score of 0 generally has lower risk of illness,
but the concurrent finding of a high-risk HRC index identifies
a subset with 2.5-fold increase in risk. For infants with 2
points or more, that is, with clinical findings of illness, knowledge of the HRC index adds little and even a low-risk HRC
index does not cancel out the clinical presentation. This is in
keeping with the idea that the HRC index is adjunctive to
clinical information, and is not a standalone substitute for
medical personnel.
DISCUSSION
We studied heart rate characteristics (HRC) and objective
findings of clinical illness in infants in a tertiary care NICU.
The major findings were (1) a validated HRC index was
correlated with clinical signs of illness and abnormal laboratory tests as well as a composite score of clinical illness
severity, and (2) the HRC index added significantly to clinical
signs and abnormal laboratory tests in predicting imminent
sepsis.
The mechanism by which sepsis leads to reduced variability
and transient decelerations of heart rate is not known, though
we speculate that circulating cytokines may interfere with
normal signal transduction in sinus node pacemaker cells.
There is substantial evidence that sepsis causes large increases
in the circulating levels of many cytokines (24), and that these
changes are evident before the clinical diagnosis of illness in
newborn infants (25). Sepsis is not the only illness in the
NICU that alters cytokine levels, and we know that the HRC
index also increases with illnesses such as necrotizing enterocolitis, intracranial hemorrhage and respiratory failure, and at
the time of surgery. Sepsis remains the focus of our work with
HRC monitoring as it is common, and it seems reasonable that
earlier diagnosis and therapy might improve outcome.
Inclusion of infants with negative blood cultures in studies of neonatal sepsis. Stoll et al. (9) in the NICHD Neonatal
Research Network recently reported on neurodevelopmental
impairment (NDI) in extremely low birth weight (1000 g,
ELBW) infants. The major finding was that infants who had
one or more episodes of infection had a 50% increase in the
already high rate of NDI. Importantly, NDI was equally
increased in infants with clinical sepsis, that is, sepsis-like
illness warranting five or more days of antibiotics despite negative blood cultures. This finding justifies inclusion of these
patients in evaluating novel means for early diagnosis of
neonatal sepsis, and it is reasonable to suspect that some of
them had bacterial sepsis that was not detected by blood
culture, an imperfect test. Certainly the NICHD Neonatal
Research Network clinicians must have believed the clinical
presentation more than the blood culture, as prolonged courses
of antibiotics were administered. Our findings of similar HRC
and clinical signs in proven and clinical sepsis are consistent
with our earlier work (11,16).
A clinical illness score relevant to neonatal sepsis. Neonatal sepsis is suspected because of clinical signs of illness.
When signs are severe enough, prolonged antibiotic therapy is
administered even if the blood culture is negative; this is
clinical sepsis. Thus using a clinical score to predict neonatal sepsis is circular since the signs are the diagnosis, they
will never fail as a diagnostic test. Laboratory tests are also
problematic, as they are much more frequently available near
the time of sepsis (19). A more stringent test of the utility of
clinical signs in early diagnosis is to analyze them before the
clinical diagnosis of sepsis, when subtle signs might be attributed to benign causes. This is the approach we used in
developing the HRC index, where the outcome of interest was
the 24 h before, but not including, the quarter-day in which the
diagnosis was made.
Here we developed and validated internally a clinical score
following a method similar to that used by Escobar and
coworkers to produce the Richardson score for neonatal mortality or prolonged ventilation (20). We began with clinical
signs that we knew were associated with sepsis, and optimized
their weighting. As expected, these signs were more predictive
of sepsis when observed at the time of diagnosis. There were,
however, highly significant associations in the preclinical
phase as well. The most predictive findings were feeding intolerance, hypotonia and lethargy, abnormal I:T ratio, severe or
increased apnea, need for increased support on mechanical ventilator, and temperature instability. The finding that I:T ratio was
the most robust independent predictor of sepsis confirms our
recent finding in a superset of this population (19).
We found a small increase in the clinical score in the 24 h
before the clinical diagnosis of illness. This finding, which
further validates the score, is not surprising since sepsis and
SIRS are preceded by a period during which cytokines are
elevated though symptoms are subtle or absent (25). This
finding confirms that of Fanaroff et al. (2) that clinical signs
were increased before the diagnosis of proven sepsis, and
extends it by combining them into a clinical illness severity
score and demonstrating similar changes before clinical sepsis. However, clinical experience teaches that the early diagnosis of neonatal sepsis and SIRS using clinical signs and
laboratory findings alone is unsatisfactory, and that new diagnostic measures are badly needed (1,26).
Surprisingly, up to 40% of infants with clinical and proven
sepsis had 0 points. Several factors could contribute to this
finding. First, several of our signs required the presence of an
abnormal clinical sign or lab test for 8 or 24 h. Thus a very
acute illness would not score points. Second, infants might
have had values near but not quite exceeding the threshold for
points. For example, an infant with a 40% increase in apnea,
18 h of feeding intolerance, one episode of temperature instability and an I:T ratio of 0.18 would have 0 points despite an
overall clinical presentation that could represent impending
sepsis. Different thresholds and different tests would lead to
different results, but scoring systems with hard cutoffs all
suffer this shortcoming.
HRC index is correlated with clinical signs of illness and
abnormal laboratory tests. We found that the HRC index was
highly significantly associated with objective clinical findings
of illness and with abnormal test results. There were correlations with individual signs and tests, and with the composite
clinical score whether measured at each 6 h time point or
averaged over the entire hospital course. Correlations were
moderate or weak in degree.
Summary. In summary, we have devised an internally
validated point score system relevant to late-onset neonatal
sepsis. We found that heart rate characteristics (HRC) monitoring is correlated with this score, adds independent information to it, and becomes abnormal before it, among infants
with clinical and proven neonatal sepsis. Since the HRC index
is continuous and in real time, it does not require any new
contact with the patient, and is significantly associated with
imminent clinical neonatal illness, we feel that it may have a
favorable impact on clinical care. While it will not replace
clinical assessment by the physician, blood cultures or other
laboratory tests, HRC monitoring can add information to
conventional measures in the early diagnosis of neonatal
sepsis.
REFERENCES
1. Stoll BJ, Hansen N, Fanaroff AA, Wright LL, Carlo WA, Ehrenkranz RA, Lemons
JA, Donovan EF, Stark AR, Tyson JE, Oh W, Bauer CR, Korones SB, Shankaran S,
Laptook AR, Stevenson DK, Papile LA, Poole WK 2002 Late-onset sepsis in very
low birth weight neonates: the experience of the NICHD Neonatal Research
Network. Pediatrics 110:285291
2. Fanaroff AA, Korones SB, Wright LL, Verter J, Poland RL, Bauer CR, Tyson JE,
Philips JB, Edwards W, Lucey JF, Catz CS, Shankaran S, Oh W 1998 Incidence,
presenting features, risk factors and significance of late onset septicemia in very low
birth weight infants. The National Institute of Child Health and Human Development
Neonatal Research Network. Pediatr Infect Dis J 17:593598
3. Kellogg JA, Ferrentino FL, Goodstein MH, Liss J, Shapiro SL, Bankert DA 1997
Frequency of low level bacteremia in infants from birth to two months of age. Pediatr
Infect Dis J 16:381385
4. Schelonka RL, Chai MK, Yoder BA, Hensley D, Brockett RM, Ascher DP 1996
Volume of blood required to detect common neonatal pathogens. J Pediatr 129:275
278
5. Neal PR, Kleiman MB, Reynolds JK, Allen SD, Lemons JA, Yu PL 1986 Volume
of blood submitted for culture from neonates. J Clin Microbiol 24:353356
6. Pierce JR, Merenstein GB, Stocker JT 1984 Immediate postmortem cultures in an
intensive care nursery. Pediatr Infect Dis 3:510513
7. Squire E, Favara B, Todd J 1979 Diagnosis of neonatal bacterial infection: hematologic and pathologic findings in fatal and nonfatal cases. Pediatrics 64:6064
227
8. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM 1988 CDC definitions for
nosocomial infections, 1988. Am J Infect Control 16:128140
9. Stoll BJ, Hansen NI, Adams-Chapman I, Fanaroff AA, Hintz SR, Vohr B, Higgins
RD 2004 Neurodevelopmental and growth impairment among extremely low-birthweight infants with neonatal infection. JAMA 292:23572365
10. American College of Chest Physicians/Society of Critical Care Medicine Consensus
Conference Committee (ACCP/SCCM) 1992 American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: Definitions for
sepsis and organ failure and guidelines for the use of innovative therapies in sepsis.
Crit Care Med 20:864874
11. Griffin MP, Moorman JR 2001 Toward the early diagnosis of neonatal sepsis and
sepsis-like illness using novel heart rate analysis. Pediatrics 107:97104
12. Moorman JR, Lake DE, Griffin MP 2006 5 Heart rate characteristics monitoring in
neonatal sepsis. IEEE Trans Biomed Eng 53:126132
13. Kovatchev BP, Farhy LS, Cao H, Griffin MP, Lake DE, Moorman JR 2003
Sample asymmetry analysis of heart rate characteristics with application to
neonatal sepsis and systemic inflammatory response syndrome. Pediatr Res 54:
892898
14. Lake DE, Richman JS, Griffin MP, Moorman JR 2002 Sample entropy analysis of
neonatal heart rate variability. Am J Physiol Regul Integr Comp Physiol.Am J Physiol 283:R789R797
15. Richman JS, Moorman JR 2000 Physiological time series analysis using approximate entropy and sample entropy. Am J Physiol Heart Circ Physiol.Am J Physiol
278:H2039H2049
16. Griffin MP, OShea TM, Bissonette EA, Harrell FE Lake DE, Moorman JR 2003
Abnormal heart rate characteristics preceding neonatal sepsis and sepsis-like illness.
Pediatr Res 53:920926
17. Griffin MP, OShea TM, Bissonette EA, Harrell FE Jr, Lake DE, Moorman JR 2004
Abnormal heart rate characteristics are associated with neonatal mortality. Pediatr
Res 55:782788
18. Griffin MP, Lake DE, Bissonette EA, Harrell FE Jr, OShea TM, Moorman JR 2005
Heart rate characteristics: novel physiomarkers to predict neonatal infection and
death. Pediatrics 116:10701074
19. Griffin MP, Lake DE, Moorman JR 2005 Heart rate characteristics and laboratory
tests in neonatal sepsis. Pediatrics 115:937941
20. Escobar GJ, Shaheen SM, Breed EM, Botas C, Greene JD, Yoshida CK, Zupancic
J, Newman TB 2004 Richardson score predicts short-term adverse respiratory
outcomes in newborns 34 weeks gestation. J Pediatr 145:754760
21. Richman JS, Lake DE, Moorman JR Sample entropy. Methods Enzymol
2004;384:172184
22. Steyerberg EW, Harrell FE, Borsboom GJ, Eijkemans MJ, Vergouwe Y, Habbema
JD 2001 Internal validation of predictive models: Efficiency of some procedures for
logistic regression analysis. J Clin Epidemiol 54:774781
23. Moons KG, Harrell FE, Steyerberg EW 2002 Should scoring rules be based on odds
ratios or regression coefficients? J Clin Epidemiol 55:10541055
24. Anderson MR, Blumer JL 1997 Advances in the therapy for sepsis in children.
Pediatr Clin North Am 44:179205
25. Kuster H, Weiss M, Willeitner AE, Detlefsen S, Jeremias I, Zbojan J, Geiger R,
Lipowsky G, Simbruner G 1998 Interleukin-1 receptor antagonist and interleukin-6
for early diagnosis of neonatal sepsis 2 days before clinical manifestation. Lancet
352:12711277
26. Stoll BJ, Gordon T, Korones SB, Shankaran S, Tyson JE, Bauer CR, Fanaroff AA,
Lemons JA, Donovan EF, Oh W, Stevenson DK, Ehrenkranz RA, Papile LA, Verter
J, Wright LL 1996 Late-onset sepsis in very low birth weight neonates: a report from
the National Institute of Child Health and Human Development Neonatal Research
Network. J Pediatr 129:6371